Back to INAB
Phase 1
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Acute Myeloid Leukemia (post haploidentical stem cell transplant)
View Full LandscapeDrug Information
Target Indication
Acute Myeloid Leukemia (post haploidentical stem cell transplant)
Mechanism of Action
Allogeneic (haplo-matched donor-derived) expanded/activated gamma-delta T cell therapy
Clinical Trial
NCT03533816Last updated: 8/14/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts